InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+7.8%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Tucker Edwin Jonathan, Directeur Médical. Officer active across 2 companies, notably Mirum Pharmaceuticals, Inc.. Cumulatively, 7 disclosures have been published. Activity tracked since 10 May 2021. The latest transaction was filed on 7 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
400 shares@ US$4.1735100.0% of flowVoting Common StockSEC:0001213900-24-051417:0
70 shares@ US$13.5150.0000% mcap2.2% of flowCommon StockSEC:0001209191-21-064453:0
70 shares@ US$13.5150.0000% mcap4.4% of flowCommon StockSEC:0001209191-21-064453
8,125 shares0Common StockSEC:0001209191-21-058604:0
8,125 shares0Common StockSEC:0001209191-21-058604
1,483 shares@ US$14.6247.8% of flowCommon StockSEC:0001209191-21-032163
1,483 shares@ US$14.620.0004% mcap47.8% of flowCommon StockSEC:0001209191-21-032163:0
7 of 7 declarations
About Tucker Edwin Jonathan
Edwin Jonathan Tucker is the Chief Medical Officer of Mirum Pharmaceuticals, Inc. In this role, he oversees the company's medical and scientific initiatives. His expertise in the pharmaceutical sector allows him to lead research and development projects. He is committed to promoting innovation and improving patient outcomes.
